A Role for Fragment-Based Drug Design in Developing Novel Lead Compounds for Central Nervous System Targets
Crossref DOI link: https://doi.org/10.3389/fneur.2015.00197
Published Online: 2015-09-11
Update policy: https://doi.org/10.3389/crossmark-policy
Wasko, Michael J.
Pellegrene, Kendy A.
Madura, Jeffry D.
Surratt, Christopher K.
Funding for this research was provided by:
National Institute on Drug Abuse (DA027806)
